Leases, Commitments and Contingencies - Consulting Agreement - Additional Information (Detail) - Consulting Agreement [Member] - USD ($)	1 Months Ended	3 Months Ended
	Jan. 31, 2014	Mar. 31, 2020	Mar. 31, 2019
Commitments And Contingencies [Line Items]
Research and development expense related to milestone expense		$ 0	$ 0
Milestone payments		$ 0	0
Clinical Development and Regulatory Milestones [Member]
Commitments And Contingencies [Line Items]
Shares of common stock for attaining milestones	126,984
Research and development expense related to milestone expense			1,800,000
Milestone payments			500,000
Payments for stock issued upon reaching a milestone			$ 1,300,000
Milestone based share compensation, shares issued			39,681
Clinical Development and Regulatory Milestones [Member] | Maximum [Member]
Commitments And Contingencies [Line Items]
Expected milestone payments	$ 2,000,000.0